330 related articles for article (PubMed ID: 32580757)
1. The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study.
Guo W; Song F; Chen S; Zhang L; Sun G; Liu J; Chen J; Liu Y; Tan N;
Trials; 2020 Jun; 21(1):567. PubMed ID: 32580757
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Kajana V; Cornara S; Somaschini A; Demarchi A; Galazzi M; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2140-2143. PubMed ID: 34039505
[TBL] [Abstract][Full Text] [Related]
3. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
[TBL] [Abstract][Full Text] [Related]
4. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
[TBL] [Abstract][Full Text] [Related]
5. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Velibey Y; Oz A; Tanik O; Guvenc TS; Kalenderoglu K; Gumusdag A; Akdeniz E; Bozbay M; Tekkesin AI; Guzelburc O; Hayiroglu MI; Alper AT; Ugur M; Eren M
Angiology; 2017 May; 68(5):419-427. PubMed ID: 27473864
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial.
Song F; Sun G; Liu J; Chen JY; He Y; Liu L; Liu Y;
Trials; 2019 May; 20(1):290. PubMed ID: 31133052
[TBL] [Abstract][Full Text] [Related]
7. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y
Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134
[TBL] [Abstract][Full Text] [Related]
8. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of admission D-dimer for contrast-induced acute kidney injury and poor outcomes after primary percutaneous coronary intervention.
Lin KY; Chen HC; Jiang H; Wang SY; Chen HM; Wu ZY; Jiang F; Guo YS; Zhu PL
BMC Nephrol; 2020 Mar; 21(1):90. PubMed ID: 32156263
[TBL] [Abstract][Full Text] [Related]
10. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
Silvain J; Nguyen LS; Spagnoli V; Kerneis M; Guedeney P; Vignolles N; Cosker K; Barthelemy O; Le Feuvre C; Helft G; Collet JP; Montalescot G
Heart; 2018 May; 104(9):767-772. PubMed ID: 29092921
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
Jarai R; Dangas G; Huber K; Xu K; Brodie BR; Witzenbichler B; Metzger DC; Radke PW; Yu J; Claessen BE; Genereux P; Mehran R; Stone GW
Circ Cardiovasc Interv; 2012 Dec; 5(6):813-20. PubMed ID: 23192919
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention.
Guo W; Liu Y; Chen JY; Chen SQ; Li HL; Duan CY; Liu YH; Tan N
Angiology; 2015 Sep; 66(8):721-6. PubMed ID: 25616679
[TBL] [Abstract][Full Text] [Related]
13. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
[TBL] [Abstract][Full Text] [Related]
16. Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score.
Araujo GN; Pivatto Junior F; Fuhr B; Cassol EP; Machado GP; Valle FH; Bergoli LC; Wainstein RV; Polanczyk CA; Wainstein MV
Cardiovasc Interv Ther; 2018 Jul; 33(3):224-231. PubMed ID: 28540634
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between carbon dioxide combining power and contrast- induced acute kidney injury in patients with ST segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention].
Ran P; Yang J; Yang X; Zhou Y; Tan N; He Y; Li G; Sun S; Liu Y; Xie N; Chen J
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jul; 42(7):551-6. PubMed ID: 25327595
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute kidney injury on long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent primary percutaneous coronary intervention in a high-volume tertiary center.
Hayıroğlu Mİ; Bozbeyoglu E; Yıldırımtürk Ö; Tekkeşin Aİ; Pehlivanoğlu S
Turk Kardiyol Dern Ars; 2020 Jan; 48(1):1-9. PubMed ID: 31974325
[TBL] [Abstract][Full Text] [Related]
20. Predictors of acute kidney injury (AKI) in high-risk ST-elevation myocardial infarction (STEMI) patients: A single-center retrospective observational study.
Sinkovič A; Masnik K; Mihevc M
Bosn J Basic Med Sci; 2019 Feb; 19(1):101-108. PubMed ID: 30589402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
